Raymond James Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Raymond James Financial's PFE Position: Q3 2026 in Review
Raymond James Financial increased its Pfizer (PFE) stake by 0.01% in Q3 2026, buying an estimated $34K and bringing the position to 11,943,333 shares worth $341M. The position accounts for 0.09% of the portfolio, ranked #191.
Raymond James Financial first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Raymond James Financial held 11,943,333 shares of Pfizer worth $341M as of Q3 2026.
- Raymond James Financial bought 1,279 Pfizer shares in Q3 2026, an estimated $34K.
- Pfizer made up 0.09% of Raymond James Financial's portfolio in Q3 2026, its #191 holding.
- Raymond James Financial first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.